Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- PMID: 32697968
- PMCID: PMC7332439
- DOI: 10.1016/j.cell.2020.06.043
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Abstract
A SARS-CoV-2 variant carrying the Spike protein amino acid change D614G has become the most prevalent form in the global pandemic. Dynamic tracking of variant frequencies revealed a recurrent pattern of G614 increase at multiple geographic levels: national, regional, and municipal. The shift occurred even in local epidemics where the original D614 form was well established prior to introduction of the G614 variant. The consistency of this pattern was highly statistically significant, suggesting that the G614 variant may have a fitness advantage. We found that the G614 variant grows to a higher titer as pseudotyped virions. In infected individuals, G614 is associated with lower RT-PCR cycle thresholds, suggestive of higher upper respiratory tract viral loads, but not with increased disease severity. These findings illuminate changes important for a mechanistic understanding of the virus and support continuing surveillance of Spike mutations to aid with development of immunological interventions.
Keywords: COVID-19; PCR cycle threshold; SARS-CoV-2; Spike; antibody; diversity; evolution; infectivity; neutralization; pseudovirus.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Figures
Comment in
-
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.Cell. 2020 Aug 20;182(4):794-795. doi: 10.1016/j.cell.2020.06.040. Epub 2020 Jul 3. Cell. 2020. PMID: 32697970 Free PMC article.
-
Emergence of a new SARS-CoV-2 variant in the UK.J Infect. 2021 Apr;82(4):e27-e28. doi: 10.1016/j.jinf.2020.12.024. Epub 2020 Dec 28. J Infect. 2021. PMID: 33383088 Free PMC article. No abstract available.
Similar articles
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.Hum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18. Hum Vaccin Immunother. 2024. PMID: 39422261 Free PMC article. Clinical Trial.
-
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo.J Virol. 2020 Oct 14;94(21):e01218-20. doi: 10.1128/JVI.01218-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32817221 Free PMC article.
-
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.Lancet Glob Health. 2020 Aug;8(8):e1003-e1017. doi: 10.1016/S2214-109X(20)30264-3. Epub 2020 Jun 15. Lancet Glob Health. 2020. PMID: 32553130 Free PMC article.
-
Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.Hum Genomics. 2020 Sep 11;14(1):30. doi: 10.1186/s40246-020-00280-6. Hum Genomics. 2020. PMID: 32917282 Free PMC article. Review.
Cited by
-
Aromatase, testosterone, TMPRSS2: determinants of COVID-19 severity.Biol Sex Differ. 2024 Oct 24;15(1):84. doi: 10.1186/s13293-024-00658-4. Biol Sex Differ. 2024. PMID: 39449074 Free PMC article.
-
Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation.J Immunol. 2021 Jun 15;206(12):3000-3009. doi: 10.4049/jimmunol.2001407. Epub 2021 Jun 2. J Immunol. 2021. PMID: 34078711 Free PMC article.
-
The effect of spike mutations on SARS-CoV-2 neutralization.Cell Rep. 2021 Mar 23;34(12):108890. doi: 10.1016/j.celrep.2021.108890. Epub 2021 Mar 6. Cell Rep. 2021. PMID: 33713594 Free PMC article.
-
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?Front Public Health. 2021 Feb 10;8:608765. doi: 10.3389/fpubh.2020.608765. eCollection 2020. Front Public Health. 2021. PMID: 33643982 Free PMC article.
-
Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2.Environ Res. 2021 May;196:110944. doi: 10.1016/j.envres.2021.110944. Epub 2021 Feb 26. Environ Res. 2021. PMID: 33647300 Free PMC article.
References
-
- Asmal M., Hellmann I., Liu W., Keele B.F., Perelson A.S., Bhattacharya T., Gnanakaran S., Daniels M., Haynes B.F., Korber B.T. A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity. PLoS ONE. 2011;6:e23673. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
